The Sle-Das Remission And Low Disease Activity States Discriminate Drug From Placebo And Better Health-Related Quality Of Life: Post-Hoc Analysis Of The Bliss-52 And Bliss-76 Phase Iii Trials.

AuthID
P-00X-E6S
5
Author(s)
Henriques, C
·
Matos, A
·
Doria, A
·
Ines, L
Document Type
Abstract
Year published
2022
Published
in ANNALS OF THE RHEUMATIC DISEASES, ISSN: 0003-4967
Volume: 81, Pages: 95-95 (1)
Indexing
Publication Identifiers
Wos: WOS:000850279000148
Source Identifiers
ISSN: 0003-4967
Export Publication Metadata
Marked List
Info
At this moment we don't have any links to full text documens.